adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
Published 3 years ago • 604 plays • Length 30:56Download video MP4
Download video MP3
Similar videos
-
2:49
procure: genomic signatures and adjuvant chemotherapy for breast cancer in europe
-
46:31
adjuvant therapy | 2023 best of breast conference
-
41:53
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
22:47
early stage breast cancer | 2022 oneoncology conference
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
31:32
2022 ku post san antonio review | early-stage hormone breast cancer: optimizing systemic therapy
-
1:05:31
adjuvant therapy for early-stage her2-positive breast cancer
-
1:25
early signs of breast cancer: dr. huma noor, consultant - medical oncology, fortis escorts
-
1:30
utilizing genomic assays for decision making in early stage breast cancer
-
30:22
adjuvant therapy | 2023 ku breast cancer year in review conference
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
41:23
optimizing adjuvant therapy throughgenomics dr. harold burstein day 1
-
11:07
adjuvant therapy for early stage er-positive, her2-negative invasive breast cancer
-
7:42
breast cancer: genomic testing for adjuvant therapy
-
29:58
genomic profiling in early stage breast cancer & role of mammaprint & blueprint testing | oncquest
-
3:51
adjuvant t-dm1 therapy for early-stage her2 breast cancer
-
3:48
adjuvant therapy for breast cancer - mayo clinic
-
4:54
adjuvant hormonal therapy for estrogen receptor positive early stage breast cancer - mayo clinic